Search

everythinglearnresearchcommunity

for

Search:↓

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Acne treatment with isotretinoin increases the presence of p53, a protein, in skin and oil glands, which may help reduce acne severity.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Cystic panfolliculoma resembles hair follicle tumors due to specific cell interactions.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.

Hedgehog pathway inhibitors could be effective in treating melanoma.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Nanoparticle systems make cancer treatment less toxic.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Both treatments for alopecia areata are equally effective and safe.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Alternative therapies like mushrooms and vinegar extracts can improve health and reduce costs for breast cancer patients.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

The treatment improved prostate health in mice.

Dupilumab may cause hair loss, so patients should be monitored.

Photodynamic therapy with methyl 5-aminolevulinic acid is ineffective for treating alopecia totalis.

Isotretinoin treatment increases p53 levels in the skin, which may explain its effectiveness against acne.

Isotretinoin treatment increases p53 levels in the skin, which may explain its effectiveness against acne.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

A new compound shows promise as a topical treatment for hair loss.